We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Executive summary of quality assurance (QA) visit to the bowel cancer screening programme in Liverpool and Wirral screening centre held on 9 June 2016.
Executive summary of quality assurance (QA) visit to the London breast screening administration hub held on 15 March 2017.
This document (RCE-7) provides advice on limiting exposure to static magnetic fields, time-varying electromagnetic fields and acoustic noise from MRI.
Qualitative insight work with Cheshire and Merseyside healthcare leaders describing current barriers and ways of supporting trusts to improve their MECC offer.
Executive summary of the quality assurance (QA) visit to Manchester University NHS Foundation Trust cervical screening programme on 7, 11 and 12 February 2020.
Executive summary of quality assurance (QA) visit to Manchester University NHS Foundation Trust held on 14 and 15 March 2018.
Guidance to help local authorities to respond to outbreaks of measles in their areas, and support greater uptake of the MMR vaccine.
Explains the part that professional appraisal and revalidation play in ensuring the ongoing quality of specialist public health practice.
These slides provide detailed training for health professionals on the new meningococcal B and meningococcal ACWY immunisation programmes.
This slideset outlines changes to the 2014 meningococcal C conjugate (MenC) vaccination programme to healthcare professionals (HCPs).
Executive summary of quality assurance (QA) visit to Merseyside and North Cheshire screening centre held on 4 March 2016.
Explains how to refer samples to PHE for Mycoplasma pneumoniae confirmation or detection of macrolide resistance markers.
Guidance for police and other organisations about how and when to seek NAIR assistance.
The NHS newborn blood spot (NBS) screening programme processes for ensuring a seamless and safe screening pathway.
Lessons learned from incidents reported to the National Chlamydia Screening Programme (NCSP).
Guidance for substance misuse commissioners on tackling new psychoactive substance (NPS) use, often called ‘legal highs.’
This document contains the newborn blood spot (NBS) screening data and reporting specifications for the Child Health Information Systems (CHIS).
Guidance and resources for carers and care providers to help people understand and access screening.
Executive summary of quality assurance (QA) visit to Norfolk and Norwich held on 15 November 2017.
Executive summary of quality assurance (QA) visit to North Middlesex University Hospital NHS Trust's cervical screening service on 3 October 2017.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).